SlideShare une entreprise Scribd logo
1  sur  27
OPENING PRAYER
DEAR HEAVENLY FATHER,
WE THANK YOU FOR GATHERING ALL OF US TODAY IN THIS IMPORTANT EVENT
MAY YOU BESTOW YOUR GUIDANCE AND BLESSINGS ON THIS EVENT,
SO THAT WE CAN ENJOY AND APPRECIATE ITS SIGNIFICANCE IN OUR LIVES
BLESS EVERYONE PRESENT HERE TODAY,
THAT EACH OF US MAY BE ABLE TO SHARE WHAT HE OR SHE HAVE,
FOR YOUR GLORY AND HONOR
GRANT GOOD HEALTH AND SAFETY TO OUR LOVED ONES LEFT AT HOME, AND PEACE AND GOOD
WILL TO ALL MEN.
MAY THE VARIOUS ACTIVITIES RELATED TO THIS EVENT BE A SUCCESS,
THROUGH YOUR INTERVENTION
WE ASK ALL OF THESE IN YOUR NAME,
AMEN.
HUMAN MONKEYPOX
By:
GERESA G. SALTA-SAMONTE,M.D.
Occupational/ Family Medicine
Infectious Diseases & Tropical Medicine
Few Questions Before We Start
 1. Are monkeys the natural reservoir of monkeypox
virus?
 2. How can we differentiate monkeypox from
chickenpox?
 3. What is the duration of quarantine if you have
been exposed to someone with monkeypox?
Background:
 1st identified in monkeys in 1958
 1st human case reported in 1970
 Endemic in areas of Africa
 Typically, only see sporadic cases outside of Africa in people who have traveled to
certain regions or have been in close contact with those travelers
 From the 1970s up until 2003, sporadic cases were identified in central and western
Africa
 Before 1980, case-fatality rate was 17% and secondary transmission was the cause in
9% of cases
 From 1981 to 1986, the case-fatality rate was 10% and secondary transmission was
the cause in 28%
 From 1996 to 1997, the largest outbreak of human monkeypox occurred, which had a
case-fatality rate of 1.5% and secondary transmission was the cause in 78%
 The 2003 outbreak, was the first documented cases in the western hemisphere with a
case-fatality rate of 0% and secondary transmission was the cause in 0%
 Cases of Monkeypox in 2022 from May 6th – 20th [2]:
 UK: 20 (Confirmed)
 Spain: 23 (Unconfirmed)
 Portugal 5 (Confirmed) + 15 (Unconfirmed)
 US 1 (Confirmed)
What is Monkeypox?
 Monkeypox is a disease caused by the monkeypox
virus. It is a viral zoonotic disease, meaning that it
can spread from animals to humans. It can also
spread between people.
 The disease is called monkeypox because it was first
identified in colonies of monkeys kept for research in
1958. It was only later detected in humans in 1970.
Mode of transmissions:
Primary infection (animal to human)
a) contact with infected animals
b) contact with infected animal products
 Secondary infection (human to human)
a) contact with infected people
b) mother to fetus
Is Monkeypox a sexually
transmitted disease?
 Monkeypox can spread from one person to another
through close physical contact, including sexual contact.
It is currently not known whether monkeypox can be
spread through sexual transmission routes (e.g., through
semen or vaginal fluids), but direct skin-to-skin contact
with lesions during sexual activities can spread the virus.
 Monkeypox rashes are sometimes found on genitals and
in the mouth, which is likely to contribute to transmission
during sexual contact. Mouth-to-skin contact could thus
cause transmission where skin or mouth lesions are
present.
Signs & symptoms
Disease Progression:
 Incubation period (5- 21 days)= the virus enters the
body & replicates. No symptoms. Virus is present in
the blood at the end of this stage
 Febrile stage ( 1-4 days)= fever is present plus other
symptoms like headache, chills, sore throat, malaise,
fatigue, swollen lymph nodes (lymphadenopathy).
Virus is present in the blood & small lesions in the
mouth may appear towards the end.
 Rash stage2 (4 weeks)
 Recovery (days to weeks)
Rash Stage
 Rash begins as maculopapular lesions of 2 to 5mm
in diameter
 Typically, centrifugal pattern (from the torso
outwards)
 Skin lesions typically progress from macular, papular,
to vesicular, to pustular, and crust phases over a 14
to 21-day period
 In patients with smallpox vaccination the rash will be
milder and only ≈50% will have lymphadenopathy
Rash stage
 Rash stage
- virus maybe in the blood in the early stage
- virus is present in the skin lesions
- antibodies are produced & detectable
 Recovery stage
- patient recovers
- antibodies are present in the blood
- scars may remain
- no more symptoms
Factors affecting the course of
the disease:
1. Asymptomatic infection may occur
2. Risk factors for severe illness:
a) children
b) immunocompromised
c) invasive route
3. Prior smallpox vaccination
Complications:
 Bacterial superinfection of skin
 Skin scarring
 Corneal scarring/vision loss
 Pneumonia
 Dehydration (secondary to painful oral lesions and
insensible fluid loss)
 Encephalitis
 Death (Very rare)
How can we protect ourselves
against monkeypox?
 by limiting contact with people who have suspected
or confirmed monkeypox.
 If you do need to have physical contact with
someone who has monkeypox because you are a
health worker or live together, encourage the
infected person to self-isolate and cover any skin
lesion if they can (e.g., by wearing clothing over the
rash).
 wear a medical mask, especially if they are
coughing or have lesions in their mouth. You should
wear one also.
 Avoid skin-to-skin contact whenever possible and
use disposable gloves if you have any direct contact
with lesions.
 Wear a mask when handling any clothes or bedding
if the person cannot do it themselves.
 Regularly clean your hands with soap and water or
an alcohol-based hand rub
 Wash the person’s clothes, towels and bedsheets
and eating utensils with warm water and detergent.
What to do when you think you
have monkeypox?
 Self-isolate
 Avoid close contact
 Clean hands regularly
 Contact your physicians
Treatment:
 There is no proven treatment for monkeypox
 For contacts of a case, recommend twice daily fever/symptom monitoring for 21 days
+ Isolation recommended
 Currently, CDC recommending airborne and contact precautions (i.e. negative
pressure room, N95, gloves, and eye shield)
 Pre-exposure smallpox vaccination has been shown to confer 85% protection against
monkeypox
 Role of post-exposure smallpox vaccination is less clear
 According to the CDC, vaccination within 4 days of exposure may prevent disease
onset and vaccination within 14 days may reduce disease severity
Opening Prayer for an Important Event
Opening Prayer for an Important Event

Contenu connexe

Similaire à Opening Prayer for an Important Event

Similaire à Opening Prayer for an Important Event (20)

Health-8-communicable diseases lesson.pptx
Health-8-communicable diseases lesson.pptxHealth-8-communicable diseases lesson.pptx
Health-8-communicable diseases lesson.pptx
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
Smallpox
 Smallpox  Smallpox
Smallpox
 
Yaws
YawsYaws
Yaws
 
MonkeyPox Virus
MonkeyPox Virus MonkeyPox Virus
MonkeyPox Virus
 
Swine Flu (H1 N1) Yusuf Yasin Kumbul
Swine Flu (H1 N1)   Yusuf Yasin KumbulSwine Flu (H1 N1)   Yusuf Yasin Kumbul
Swine Flu (H1 N1) Yusuf Yasin Kumbul
 
MEASLES - THEORY.ppt
MEASLES - THEORY.pptMEASLES - THEORY.ppt
MEASLES - THEORY.ppt
 
Monkeypox RA and Mx 27 Mei 2022.pptx
Monkeypox RA and Mx 27 Mei 2022.pptxMonkeypox RA and Mx 27 Mei 2022.pptx
Monkeypox RA and Mx 27 Mei 2022.pptx
 
monkeypox- amended 2.pptx
monkeypox- amended 2.pptxmonkeypox- amended 2.pptx
monkeypox- amended 2.pptx
 
Chickenpox and smallpox
Chickenpox  and  smallpoxChickenpox  and  smallpox
Chickenpox and smallpox
 
Corona ebook
Corona ebookCorona ebook
Corona ebook
 
Tuberculosis.man
Tuberculosis.manTuberculosis.man
Tuberculosis.man
 
Ready Army: Swine influenza
Ready Army: Swine influenza Ready Army: Swine influenza
Ready Army: Swine influenza
 
SUMMARIZE EACH SECTION OF THE.pdf
SUMMARIZE EACH SECTION OF THE.pdfSUMMARIZE EACH SECTION OF THE.pdf
SUMMARIZE EACH SECTION OF THE.pdf
 
Staph research paper
Staph research paperStaph research paper
Staph research paper
 
Monkeypox_An overview.pptx
Monkeypox_An overview.pptxMonkeypox_An overview.pptx
Monkeypox_An overview.pptx
 
Corona ebook.pdf.pdf.pdf
Corona ebook.pdf.pdf.pdfCorona ebook.pdf.pdf.pdf
Corona ebook.pdf.pdf.pdf
 
SUMMARIZE EACH SECTION OF THE Identify.pdf
SUMMARIZE EACH SECTION OF THE Identify.pdfSUMMARIZE EACH SECTION OF THE Identify.pdf
SUMMARIZE EACH SECTION OF THE Identify.pdf
 
Monkeypox Disease.pptx
Monkeypox Disease.pptxMonkeypox Disease.pptx
Monkeypox Disease.pptx
 
Dns
DnsDns
Dns
 

Dernier

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 

Dernier (20)

PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 

Opening Prayer for an Important Event

  • 1.
  • 2. OPENING PRAYER DEAR HEAVENLY FATHER, WE THANK YOU FOR GATHERING ALL OF US TODAY IN THIS IMPORTANT EVENT MAY YOU BESTOW YOUR GUIDANCE AND BLESSINGS ON THIS EVENT, SO THAT WE CAN ENJOY AND APPRECIATE ITS SIGNIFICANCE IN OUR LIVES BLESS EVERYONE PRESENT HERE TODAY, THAT EACH OF US MAY BE ABLE TO SHARE WHAT HE OR SHE HAVE, FOR YOUR GLORY AND HONOR GRANT GOOD HEALTH AND SAFETY TO OUR LOVED ONES LEFT AT HOME, AND PEACE AND GOOD WILL TO ALL MEN. MAY THE VARIOUS ACTIVITIES RELATED TO THIS EVENT BE A SUCCESS, THROUGH YOUR INTERVENTION WE ASK ALL OF THESE IN YOUR NAME, AMEN.
  • 3. HUMAN MONKEYPOX By: GERESA G. SALTA-SAMONTE,M.D. Occupational/ Family Medicine Infectious Diseases & Tropical Medicine
  • 4. Few Questions Before We Start  1. Are monkeys the natural reservoir of monkeypox virus?  2. How can we differentiate monkeypox from chickenpox?  3. What is the duration of quarantine if you have been exposed to someone with monkeypox?
  • 6.  1st identified in monkeys in 1958  1st human case reported in 1970  Endemic in areas of Africa  Typically, only see sporadic cases outside of Africa in people who have traveled to certain regions or have been in close contact with those travelers  From the 1970s up until 2003, sporadic cases were identified in central and western Africa  Before 1980, case-fatality rate was 17% and secondary transmission was the cause in 9% of cases  From 1981 to 1986, the case-fatality rate was 10% and secondary transmission was the cause in 28%  From 1996 to 1997, the largest outbreak of human monkeypox occurred, which had a case-fatality rate of 1.5% and secondary transmission was the cause in 78%  The 2003 outbreak, was the first documented cases in the western hemisphere with a case-fatality rate of 0% and secondary transmission was the cause in 0%  Cases of Monkeypox in 2022 from May 6th – 20th [2]:  UK: 20 (Confirmed)  Spain: 23 (Unconfirmed)  Portugal 5 (Confirmed) + 15 (Unconfirmed)  US 1 (Confirmed)
  • 7. What is Monkeypox?  Monkeypox is a disease caused by the monkeypox virus. It is a viral zoonotic disease, meaning that it can spread from animals to humans. It can also spread between people.  The disease is called monkeypox because it was first identified in colonies of monkeys kept for research in 1958. It was only later detected in humans in 1970.
  • 8. Mode of transmissions: Primary infection (animal to human) a) contact with infected animals b) contact with infected animal products  Secondary infection (human to human) a) contact with infected people b) mother to fetus
  • 9.
  • 10.
  • 11. Is Monkeypox a sexually transmitted disease?  Monkeypox can spread from one person to another through close physical contact, including sexual contact. It is currently not known whether monkeypox can be spread through sexual transmission routes (e.g., through semen or vaginal fluids), but direct skin-to-skin contact with lesions during sexual activities can spread the virus.  Monkeypox rashes are sometimes found on genitals and in the mouth, which is likely to contribute to transmission during sexual contact. Mouth-to-skin contact could thus cause transmission where skin or mouth lesions are present.
  • 13. Disease Progression:  Incubation period (5- 21 days)= the virus enters the body & replicates. No symptoms. Virus is present in the blood at the end of this stage  Febrile stage ( 1-4 days)= fever is present plus other symptoms like headache, chills, sore throat, malaise, fatigue, swollen lymph nodes (lymphadenopathy). Virus is present in the blood & small lesions in the mouth may appear towards the end.  Rash stage2 (4 weeks)  Recovery (days to weeks)
  • 14. Rash Stage  Rash begins as maculopapular lesions of 2 to 5mm in diameter  Typically, centrifugal pattern (from the torso outwards)  Skin lesions typically progress from macular, papular, to vesicular, to pustular, and crust phases over a 14 to 21-day period  In patients with smallpox vaccination the rash will be milder and only ≈50% will have lymphadenopathy
  • 16.
  • 17.
  • 18.  Rash stage - virus maybe in the blood in the early stage - virus is present in the skin lesions - antibodies are produced & detectable  Recovery stage - patient recovers - antibodies are present in the blood - scars may remain - no more symptoms
  • 19.
  • 20. Factors affecting the course of the disease: 1. Asymptomatic infection may occur 2. Risk factors for severe illness: a) children b) immunocompromised c) invasive route 3. Prior smallpox vaccination
  • 21. Complications:  Bacterial superinfection of skin  Skin scarring  Corneal scarring/vision loss  Pneumonia  Dehydration (secondary to painful oral lesions and insensible fluid loss)  Encephalitis  Death (Very rare)
  • 22. How can we protect ourselves against monkeypox?  by limiting contact with people who have suspected or confirmed monkeypox.  If you do need to have physical contact with someone who has monkeypox because you are a health worker or live together, encourage the infected person to self-isolate and cover any skin lesion if they can (e.g., by wearing clothing over the rash).  wear a medical mask, especially if they are coughing or have lesions in their mouth. You should wear one also.
  • 23.  Avoid skin-to-skin contact whenever possible and use disposable gloves if you have any direct contact with lesions.  Wear a mask when handling any clothes or bedding if the person cannot do it themselves.  Regularly clean your hands with soap and water or an alcohol-based hand rub  Wash the person’s clothes, towels and bedsheets and eating utensils with warm water and detergent.
  • 24. What to do when you think you have monkeypox?  Self-isolate  Avoid close contact  Clean hands regularly  Contact your physicians
  • 25. Treatment:  There is no proven treatment for monkeypox  For contacts of a case, recommend twice daily fever/symptom monitoring for 21 days + Isolation recommended  Currently, CDC recommending airborne and contact precautions (i.e. negative pressure room, N95, gloves, and eye shield)  Pre-exposure smallpox vaccination has been shown to confer 85% protection against monkeypox  Role of post-exposure smallpox vaccination is less clear  According to the CDC, vaccination within 4 days of exposure may prevent disease onset and vaccination within 14 days may reduce disease severity